New Jersey Better Educational Savings Trust’s Aratana Therapeutics, Inc. PETX Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$292K	–	217
2018 Q3	$292K	Hold	50,000	–	–	0.3%	140
2018 Q2	$213K	Sell	50,000 -4,000	-7%	-$20.2K	0.23%	157
2018 Q1	$238K	Buy	54,000 +4,000	+8%	+$17.8K	0.26%	142
2017 Q4	$263K	Buy	+50,000	New	+$306K	0.27%	142

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

New Jersey Better Educational Savings Trust's PETX Position: Q4 2018 in Review

New Jersey Better Educational Savings Trust sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2018, closing a stake of 50,000 shares — an estimated $292K sold.

New Jersey Better Educational Savings Trust first reported a position in PETX in Q4 2017 and held it in 4 quarters. The position peaked at $292K in Q3 2018. 115 funds tracked by Wall St. Rank hold PETX as of Q4 2018.

New Jersey Better Educational Savings Trust reported no remaining Aratana Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
New Jersey Better Educational Savings Trust sold 50,000 Aratana Therapeutics, Inc. shares in Q4 2018, an estimated $292K.
New Jersey Better Educational Savings Trust first reported a position in Aratana Therapeutics, Inc. in Q4 2017 and held it in 4 quarters.
New Jersey Better Educational Savings Trust's Aratana Therapeutics, Inc. position peaked at $292K in Q3 2018.
115 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2018.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q4 2018, filed 24 Jan 2019.